Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Moleculin Biotech announces plan for clinical trial drug production
Saturday, October 08, 2016Moleculin Biotech Inc Has secured an agreement with Dermin Sp Zo O Dermin to utilize Dermins supply of Annamycin for its upcoming clinical trial Agreement reached allows company to utilize Annamycin in upcoming clinical trials rather than having to...
Astellas Filed Lawsuit against Patent Infringement of Myrbetriq® in the United States
Friday, October 07, 2016Astellas Pharma Inc and its subsidiaries jointly filed a lawsuit against Actavis Elizabeth LLC and its affiliates Actavis who filed an abbreviated new drug application ANDA for a generic version of Astellas mirabegron generic name product sold under...
RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan
Friday, October 07, 2016RaQualia Pharma Inc Says it received substance patent for ghrelin receptor agonistserine derivative in Japan Says the substance is used for improvement of anorexia and suppression of body weight reduction Source reuterscom
Thousands of European melanoma patients lack access to new drugs
Friday, October 07, 2016More than a quarter of European patients with advanced melanoma lack access to new treatments that could extend their lives according to findings presented at a major cancer conference on Friday In the last five years novel medicines have revolution...
Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products
Friday, October 07, 2016Lupin Pharmaceutical Inc the US subsidiary of pharma major Lupin Limited collectively Lupin and MonoSol Rx a specialty pharmaceutical company have entered into a strategic licensing agreement wherein Lupin would develop multiple pediatric products ut...
AstraZeneca licenses respiratory drug to Insmed
Thursday, October 06, 2016Drugmaker Insmed Inc said on Wednesday it had bought the rights to an experimental earlystage respiratory drug from Britains AstraZeneca Plc in a deal worth million AstraZeneca will get million in upfront fees and million in various milestone pay...
Novartis reshapes research, closes some Swiss, Chinese units
Thursday, October 06, 2016Novartis is closing some of its research operations in Switzerland and China and cutting jobs part of the Swiss drug makers effort to centralize control over its drug discovery programs and contain costs Novartis which employs globally is also rel...
U.S. government health plans spent over $1 billion on EpiPens over five years
Thursday, October 06, 2016US government health plans spent more than billion on Mylan NVs EpiPen emergency allergic reaction treatment between and according to figures released by the Centers for Medicare and Medicaid Services on Wednesday Mylan is under scrutiny for rais...
Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland
Thursday, October 06, 2016Intas Pharmaceuticals Ltd through its wholly owned subsidiary Accord Healthcare Ltd announced today that it has entered into definitive agreements to acquire Actavis UK Ltd Actavis Ireland Ltd Actavis UK Ireland from Teva Pharmaceutical Industries...
Sanofi's dengue vaccine approved in 11 countries
Wednesday, October 05, 2016Sanofi Pasteur Sanofis vaccines unit said on Tuesday that its dengue vaccine Dengvaxia had received market approval in eleven countries To date the vaccine has been approved in Mexico the Philippines Brazil El Salvador Costa Rica Paraguay Guatemala...
